Apogee Therapeutics ( (APGE) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Apogee Therapeutics’ stock experienced a significant rise, driven by strong trial results and solid financial health, which led analysts to increase the price target from $78 to $87. The stock also received an Outperform rating from RBC Capital, indicating a positive outlook from Wall Street.
More about Apogee Therapeutics
YTD Price Performance: -15.74%
Average Trading Volume: 604,202
Technical Sentiment Signal: Buy
Current Market Cap: $2.37B
For further insights into APGE stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.